Metropolis bets on selective M&A, targets 27-28% EBITDA margin in three years

“We don't see the diagnostics industry as an inorganic industry at all. Actually, it is an industry which is built on the back of execution on the ground,” Executive Chairperson Ameera Shah told Moneycontrol.